Chapter title |
Vaccinia Virus Protein C6: A Multifunctional Interferon Antagonist
|
---|---|
Book title |
Infectious Diseases and Nanomedicine III
|
Published in |
Advances in experimental medicine and biology, January 2018
|
DOI | 10.1007/978-981-10-7572-8_1 |
Pubmed ID | |
Book ISBNs |
978-9-81-107571-1, 978-9-81-107572-8
|
Authors |
Geoffrey L. Smith |
Abstract |
Vaccinia virus (VACV) is the prototypic member of the Orthopoxvirus genus of the Poxviridae. It is also the live vaccine that was used to eradicate smallpox. Like other poxviruses, VACV replicates in the cytoplasm and has a large double-stranded (ds)DNA genome and a complex virion. Approximately, half of the VACV genes are nonessential for virus replication in cell culture but encode a remarkable array of immunomodulators that antagonise the innate immune response to virus infection. This short review concerns one such protein, C6, that is a multifunctional inhibitor of interferon. C6 can both diminish the production of interferon and inhibit interferon-induced signalling and thereby the expression of interferon-stimulated genes. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 12 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 25% |
Student > Bachelor | 3 | 25% |
Student > Master | 3 | 25% |
Librarian | 1 | 8% |
Student > Ph. D. Student | 1 | 8% |
Other | 0 | 0% |
Unknown | 1 | 8% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 4 | 33% |
Medicine and Dentistry | 3 | 25% |
Agricultural and Biological Sciences | 2 | 17% |
Immunology and Microbiology | 1 | 8% |
Unknown | 2 | 17% |